Skip to main content

Table 3 Patient-reported outcome measures for each year from 2008 to 2017 for patients with psoriatic arthritis monitored in an ordinary outpatient clinic

From: Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

Year (patients)

MHAQ (0–3)

Pain (VAS, mm)

Joint pain (VAS, mm)

Fatigue (VAS, mm)

Morning stiffness (h)

PGA (VAS, mm)

2008 (n = 106)

0.59 (0.53) 59.4%]

37.5 (24.6) [56.6%]

41.1 (25.2) 36 [34.0%]

44.5 (32.4) [58.5%]

1.24 (1.48) [58.5%]

41.3 (26.0) [58.5%]

2009 (n = 268)

0.46 (0.44) [85.8%]

37.5 (22.1) [84.3%]

38.1 (23.0) [84.3%]

47.0 (30.2) [84.7%]

0.93 (1.05) [85.1%]

40.3 (24.4) [87.3%]

2010 (n = 318)

0.45 (0.43) [93.4%]

37.4 (23.4) [93.1%]

36.2 (23.5) [91.8%]

43.2 (31.1) [92.1%]

0.90 (1.15) [92.8%]

37.6 (23.3) [93.7%]

2011 (n = 365)

0.44 (0.42) [89.9%]

36.1 (24.2) [89.6%]

35.4 (24.1) [89.3%]

44.9 (30.6) [89.3%]

0.90 (1.21) [90.4%]

37.1 (23.9) [91.5%]

2012 (n = 377)

0.44 (0.43) [89.7%]

36.2 (24.5) [89.7%]

35.6 (24.7) [89.7%]

42.9 (30.2) [89.7%]

0.93 (1.27) [89.1%]

37.6 (25.6) [91.0%]

2013 (n = 397)

0.42 (0.40) [90.1%]

33.9 (25.5) [90.2%]

33.8 (23.7) [90.7%]

42.6 (31.0) [90.4%]

0.87 (1.15) [90.7%]

37.4 (26.2) [90.9%]

2014 (n = 412)

0.45 (0.44) [90.0%]

35.8 (24.7) [89.1%]

35.0 (24.7) [87.1%]

42.7 (31.3) [87.1%]

0.89 (1.14) [86.7%]

37.9 (26.5) [91.3%]

2015 (n = 384)

0.47 (0.43) [91.4%]

38.4 (26.5) [91.1%]

36.2 (26.6) [90.1%]

45.5 (32.6) [90.4%]

0.97 (1.27) [89.8%]

40.1 (28.2) [93.0%]

2016 (n = 340)

0.51 (0.46) [87.6%]

38.8 (26.8) [86.2%]

38.3 (26.5) [87.4%]

45.2 (32.2) [87.6%]

1.06 (1.36) [86.8%]

40.6 (27.8) [87.9%]

2017 (n = 341)

0.51 (0.45) [89.4%]

39.8 (26.4) [89.4%]

38.7 (26.3) [89.4%]

45.1 (32.7) [89.1%]

1.03 (1.27) [89.7%]

40.6 (27.9) [90.6%]

Mean for the period

0.46 (0.44)

37.0 (24.8)

36.3 (24.9)

44.2 (31.3)

0.95 (1.22)

38.8 (26.0)

P valuea 2008–2017

0.11

0.10

0.44

0.90

0.26

0.18

P valuea 2013–2017

0.002

0.001

0.003

0.16

0.025

0.06

  1. Values are shown as mean (standard deviation)
  2. The percentages within square brackets represent patients with available data
  3. MHAQ Modified Health Assessment Questionnaire, PGA patient’s global assessment, VAS visual analog scale
  4. a Linear regression was used to test for differences during follow-up